Understanding the Cost Landscape

One of the most common questions patients have about ketamine therapy is cost. Because the pricing structure differs significantly between FDA-approved Spravato and off-label IV ketamine — and because insurance coverage varies — understanding the financial picture is essential for treatment planning.

IV Ketamine Infusion Costs

IV ketamine for psychiatric indications is administered off-label, which means it is generally not covered by health insurance. Patients should expect to pay out of pocket.

Typical Pricing

  • Single infusion: $400–$800 per session, depending on geographic location, clinic overhead, and provider credentials
  • Induction series (6 infusions): $2,400–$4,800 total. Many clinics offer package pricing that reduces the per-infusion cost
  • Maintenance boosters: Same per-session range, typically needed every 2–6 weeks for responders

What Affects Pricing

Costs vary based on several factors:

  • Provider type: Board-certified psychiatrists and anesthesiologists may charge more than nurse practitioners, reflecting differences in training and oversight capabilities
  • Location: Urban clinics in high cost-of-living areas tend to charge more
  • Monitoring level: Clinics with continuous cardiac monitoring, dedicated nursing staff, and physician presence during infusions may have higher overhead
  • Session duration: Some clinics offer extended integration sessions or longer infusion times at additional cost

Spravato (Esketamine) Costs and Insurance

Because Spravato is FDA-approved, insurance coverage is more widely available — though not guaranteed.

With Insurance

  • Many commercial insurance plans and Medicare Part D cover Spravato, though prior authorization is typically required
  • Copays range from $0–$250 per session depending on your plan
  • Janssen offers a Spravato savings program that can reduce out-of-pocket costs for commercially insured patients

Without Insurance

  • The list price of Spravato is approximately $590–$885 per session (for 56 mg and 84 mg doses, respectively)
  • Additional facility fees for the required 2-hour monitored administration add to total costs

Financial Assistance and Payment Options

Several options may help make ketamine therapy more accessible:

  • Clinic payment plans: Many ketamine clinics offer interest-free payment plans or financing through medical credit companies like CareCredit or Prosper Healthcare Lending
  • HSA/FSA accounts: Ketamine therapy may be eligible for payment through Health Savings Accounts or Flexible Spending Accounts — check with your plan administrator
  • Manufacturer programs: Janssen's Spravato With Me program provides copay assistance and support coordinators
  • Clinical trials: Patients who qualify for active clinical trials may receive treatment at no cost. ClinicalTrials.gov lists current ketamine-related studies

Cost vs. Value: A Broader Perspective

While ketamine therapy represents a significant financial investment, it is worth considering in context. Treatment-resistant depression carries substantial direct and indirect costs — ongoing medication trials, therapy appointments, lost productivity, disability, and emergency care. For patients who respond to ketamine, the rapid improvement in function may offset costs over time.

That said, cost should never be the sole determinant of treatment decisions. Discuss all options, including non-ketamine alternatives, with your healthcare provider.

This article is for informational purposes only. Costs cited are approximate and vary by region and provider. Contact clinics directly for current pricing.